Legal & General Group’s Caribou Biosciences CRBU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.7K Buy
+8,904
New +$17.6K ﹤0.01% 3210
2025
Q2
Sell
-6,941
Closed -$6.34K 3443
2025
Q1
$6.34K Hold
6,941
﹤0.01% 3246
2024
Q4
$11K Hold
6,941
﹤0.01% 3235
2024
Q3
$13.6K Hold
6,941
﹤0.01% 3194
2024
Q2
$11.4K Hold
6,941
﹤0.01% 3268
2024
Q1
$35.7K Hold
6,941
﹤0.01% 2823
2023
Q4
$39.8K Buy
6,941
+747
+12% +$3.69K ﹤0.01% 2838
2023
Q3
$29.6K Buy
6,194
+684
+12% +$4.24K ﹤0.01% 2924
2023
Q2
$23.4K Sell
5,510
-2,249
-29% -$10.1K ﹤0.01% 3049
2023
Q1
$41.2K Sell
7,759
-10,437
-57% -$65K ﹤0.01% 2911
2022
Q4
$114K Buy
18,196
+429
+2% +$3.82K ﹤0.01% 2790
2022
Q3
$188K Buy
17,767
+1,294
+8% +$12.1K ﹤0.01% 2655
2022
Q2
$89K Buy
16,473
+5,240
+47% +$40.1K ﹤0.01% 2885
2022
Q1
$103K Buy
11,233
+3,080
+38% +$32.5K ﹤0.01% 2856
2021
Q4
$123K Buy
8,153
+6,355
+353% +$124K ﹤0.01% 2866
2021
Q3
$43K Buy
+1,798
New +$44K ﹤0.01% 3017

Other funds holding CRBU

Legal & General Group's CRBU Position: Q2 2026 in Review

Legal & General Group opened a new position in Caribou Biosciences (CRBU) in Q2 2026: 8,904 shares worth $15.7K. The stake represents ﹤0.01% of the portfolio and ranks #3210 among its holdings. This is a return to the name: Legal & General Group previously reported a position in CRBU as recently as Q1 2025.

Legal & General Group first reported a position in CRBU in Q3 2021 and has held it in 16 quarters since. The position peaked at $188K in Q3 2022. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Legal & General Group held 8,904 shares of Caribou Biosciences worth $15.7K as of Q2 2026.
  • Caribou Biosciences was a new Legal & General Group position in Q2 2026.
  • Caribou Biosciences made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #3210 holding.
  • Legal & General Group first reported a position in Caribou Biosciences in Q3 2021 and has held it in 16 quarters since.
  • Legal & General Group's Caribou Biosciences position peaked at $188K in Q3 2022.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.